Skip to Main Content

Author Details

Gary Michael Felker
Duke University School of Medicine
1992
438
86
PMIDPaper TitleJournal TitlePublished Year
37816446Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study.J Card Fail2024
38069997Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper.JACC Heart Fail2024
37897462Managing Obesity in Heart Failure: A Chance to Tip the Scales?JACC Heart Fail2024
37990754Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS-986231).Eur J Heart Fail2024
37683911The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF.J Card Fail2024
36114655Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction.Eur J Heart Fail2023
37634520Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.Lancet2023
37666729Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure.Am J Cardiol2023
37632309Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartan.ESC Heart Fail2023
37950896Addition by Subtraction in Mechanical Cardiac Support.JAMA2023
37831045Sex Differences in Heart Failure With Reduced Ejection Fraction in the GALACTIC-HF Trial.JACC Heart Fail2023
37935635Endpoint adjudication in cardiovascular clinical trials.Eur Heart J2023
37733308Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.N Engl J Med2023
37565976Blood Volume Analysis-Guided Heart Failure Management: A Pilot Randomized Controlled Trial.JACC Heart Fail2023
37192287Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction.Circ Heart Fail2023
36990549Critical Care Enrichment During Advanced Heart Failure Training.J Am Coll Cardiol2023
37117140Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.J Card Fail2023
37116604Electronic health record characterization and outcomes of heart failure with preserved ejection fraction.Am Heart J2023
37115133Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.JACC Heart Fail2023
37115131Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan.JACC Heart Fail2023
37078276Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States.Circ Heart Fail2023
37042286Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure.J Am Heart Assoc2023
37401523Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan.Eur J Heart Fail2023
37098791Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.Eur J Heart Fail2023
37331690Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial.J Card Fail2023
37462255Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.Eur J Heart Fail2023
36889884Considering Addition of Acetazolamide to Loop Diuretics as Treatment for Acute Heart Failure: ADVOR Reappraisal.JACC Heart Fail2023
36656377Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure.Clin Res Cardiol2023
36592843Trajectory of Decongestion and Mortality in Young Adults with Acute Heart Failure.Curr Probl Cardiol2023
36924335Splanchnic nerve block with botulinum toxin for therapy of chronic heart failure - mechanism of action (SPONGE-HF).Eur J Heart Fail2023
36924209Long-term outcomes of phenoclusters in severe tricuspid regurgitation.Eur Heart J2023
36881395Medication-Attributable Adverse Events in Heart Failure Trials.JACC Heart Fail2023
36881396Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HF.JACC Heart Fail2023
36915227Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial.Eur J Heart Fail2023
36802884Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study.Circulation2023
36633838Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA2023
36599549Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan.JACC Heart Fail2023
36632934Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure.J Card Fail2023
36597719Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trial.Eur J Heart Fail2023
36351495Duration of Heart Failure, In-hospital Clinical Trajectory, and Postdischarge Outcomes in Patients Hospitalized for Heart Failure.J Card Fail2023
36350794Time to diuretics in acute heart failure: the tortoise or the hare?Eur J Heart Fail2023
34784657The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.ESC Heart Fail2022
35574959Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-Analysis.J Am Heart Assoc2022
35462033Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial.J Card Fail2022
35490873Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT study.Prog Cardiovasc Dis2022
35852527Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.JAMA2022
35361446Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.JACC Heart Fail2022
35483801Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction.JACC Heart Fail2022
35483537Quantitative Blood Volume Analysis and Hemodynamic Measures of Vascular Compliance in Patients With Worsening Heart Failure.J Card Fail2022
35654972Plasma metabolites associated with functional and clinical outcomes in heart failure with reduced ejection fraction with and without type 2 diabetes.Sci Rep2022
  • 1 - 50 of 438

Recommended Authors

Mohammad Al-Ani
University of Florida Gainesville
Career Start Year 2015
Number of shared co-authors 0
Andrew N Rosenbaum
Mayo Clinic
Career Start Year 2011
Number of shared co-authors 4
Mustafa M Ahmed
University of Florida
Career Start Year 2011
Number of shared co-authors 1
Eugene C DePasquale
Ronald Reagan university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 2
Miguel Tavares
Hospital de Santo Antonio - Centro Hospitalar Universitario Do Porto
Career Start Year 2007
Number of shared co-authors 17
Martin Cadeiras
UC Davis Medical Center
Career Start Year 2007
Number of shared co-authors 1
Ayesha Hasan
The Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 11
Ravi V Desai
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 3
Beth Towery Davidson
TriStar Centennial Medical Center
Career Start Year 2004
Number of shared co-authors 5
Tobias Breidthardt
University Hospital Basel, University of Basel
Career Start Year 2001
Number of shared co-authors 10
Iwan C C van der Horst
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University
Career Start Year 2001
Number of shared co-authors 2
Mikhail Kosiborod
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Career Start Year 2001
Number of shared co-authors 34
Tamara B Horwich
university of california los angeles School of Medicine
Career Start Year 2001
Number of shared co-authors 7
Benjamin M Scirica
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 18
Robert L McNamara
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 13
Juan M Aranda
University of Florida
Career Start Year 1997
Number of shared co-authors 3
Frederick A Masoudi
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 39
Lori B Daniels
University of California San Diego (university of california san diego)
Career Start Year 1993
Number of shared co-authors 22
Peter A McCullough
Truth for Health Foundation
Career Start Year 1992
Number of shared co-authors 28
R. Scott Wright
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 11
Vinay Thohan
Mission Hospital
Career Start Year 1989
Number of shared co-authors 21
Stuart D Katz
NYU Grossman School of Medicine
Career Start Year 1988
Number of shared co-authors 13
Sergio V Perrone
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Career Start Year 1988
Number of shared co-authors 15
Mariell Jessup
University of Pennsylvania Perelman School of Medicine
Career Start Year 1987
Number of shared co-authors 33
Serge Masson
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Career Start Year 1986
Number of shared co-authors 12
Charles A Herzog
Hennepin Healthcare/University of Minnesota
Career Start Year 1984
Number of shared co-authors 8
Christiane E Angermann
University and University Hospital Wurzburg
Career Start Year 1976
Number of shared co-authors 13
Robert O Bonow
Northwestern University Feinberg School of Medicine
Career Start Year 1972
Number of shared co-authors 37
Bernard J Gersh
Mayo Clinic College of Medicine and Science
Career Start Year 1969
Number of shared co-authors 38
Arthur Mark Richards
National University Heart Centre Singapore
Career Start Year 1964
Number of shared co-authors 24

Collaborators

Adrian F Hernandez
Duke University Medical Center
Co-authored papers 98
John R Teerlink
Cardiology University of California San Francisco (UCSF)
Co-authored papers 82
Gerasimos Filippatos
National and Kapodistrian University of Athens, Attikon University Hospital
Co-authored papers 54
Ileana L Pi??a
Thomas Jefferson University
Co-authored papers 47
Kevin J Anstrom
University of North Carolina at Chapel Hill
Co-authored papers 40
Peter S Pang
Indiana University School of Medicine
Co-authored papers 37
Adam D DeVore
Duke University School of Medicine, NC Duke Clinical Research Institute
Co-authored papers 31
Joseph G Rogers
The Texas Heart Institute
Co-authored papers 30
Gregg C Fonarow
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 28
Marat Fudim
Duke University Medical Center, Duke Clinical Research Institute
Co-authored papers 27
Chetan B Patel
Duke University Hospital
Co-authored papers 25
Carmelo A Milano
Duke University Medical Center
Co-authored papers 22
Eugene Braunwald
Co-authored papers 21
John G F Cleland
British Heart Foundation Centre of Research Excellence, University of Glasgow
Co-authored papers 20
Mihai Gheorghiade
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 16
Eric J Velazquez
Yale School of Medicine
Co-authored papers 14
William E Kraus
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers 13
Robert M Califf
From the National Institutes of Health
Co-authored papers 12
Alan S Maisel
University of California
Co-authored papers 11
Phillip D Levy
Wayne State University School of Medicine.
Co-authored papers 10
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 10
Kenneth B Margulies
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 9
Svati H Shah
Duke Molecular Physiology Institute
Co-authored papers 9
Paul A Heidenreich
Stanford University School of Medicine
Co-authored papers 8
Barry M Massie
University of California at San Francisco
Co-authored papers 8
Manesh R Patel
Duke Clinical Research Institute
Co-authored papers 8
Jeffrey M Testani
Yale University School of Medicine
Co-authored papers 8
Phillip J Schulte
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 7
JoAnn Lindenfeld
Vanderbilt University Medical Center
Co-authored papers 7
Norman Stockbridge
Center for Drug Evaluation and Research
Co-authored papers 6
Release 1.2